Articolul precedent |
Articolul urmator |
399 15 |
Ultima descărcare din IBN: 2023-03-30 13:07 |
SM ISO690:2012 GRECHIN, Adrian. Biomarkerii sindromului metabolic. In: Culegere de rezumate ştiinţifice ale studenţilor, rezidenţilor şi tinerilor cercetători, 16-18 octombrie 2019, Chișinău. Chișinău, Republica Moldova: CEP ”Medicina”, 2019, p. 163. ISBN 978-9975-82-148-3. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Culegere de rezumate ştiinţifice ale studenţilor, rezidenţilor şi tinerilor cercetători 2019 | ||||||
Conferința "Culegere de rezumate ştiinţifice ale studenţilor, rezidenţilor şi tinerilor cercetători" Chișinău, Moldova, 16-18 octombrie 2019 | ||||||
|
||||||
Pag. 163-163 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Introducere. Sindromul metabolic (MetS) reprezintă un grup de dereglări metabolice asociate, ce include obezitatea centrală, hipertensiunea, dislipidemia, hiperglicemia și rezistența la insulină. Sindromul metabolic este o afecțiune progresivă care cuprinde o gamă largă de afecțiuni cu tulburări metabolice specifice care pot fi detectate și monitorizate prin intermediul unor biomarkeri serici. Introduction. Metabolic syndrome (MetS) represents a cluster of related metabolic abnormalities, including central obesity, hypertension, dyslipidemia, hyperglycemia, with central obesity and insulin resistance. These abnormalities can be detected and monitored via serum biomarkers. Objective of the study. To compile a list of promising biomarkers that are associated with metabolic syndrome and this panel can aid in early detection and management of metabolic syndrome in high risk populations. Material and methods. Literature review was conducted using the PubMed search engine. The following key-words were used in order to search for biomedical literature: metabolic syndrome, adipokines, neuropeptides, pro-inflammatory and anti-inflammatory cytokines, markers of antioxidant status and prothrombotic factors. Results. According to the literature, the concentrations of pro-inflammatory cytokines (IL-6, TNF-α), markers of pro-oxidant status (OxLDL, uric acid) and prothrombotic factors (PAI-1) were elevated in metabolic syndrome. Additionally, leptin concentrations were found to be elevated in metabolic syndrome as well, likely due to leptin resistance. Concentrations of anti-inflammatory cytokines (IL-10), ghrelin, adiponectin, and antioxidant factors (PON-1) were decreased in metabolic syndrome. Conclusion. The aforementioned biomarkers correlate significantly with metabolic syndrome and could provide minimally-invasive means for early detection and specific treatment of these disorders. |
||||||
Cuvinte-cheie biomarkeri, sindrom metabolic, biomarkers, metabolic syndrome |
||||||
|